Analyst firms · BTIG · NEO
BTIG NEO price target and rating history
NeoGenomics Inc. (NEO) · Health Care
BTIG rates NeoGenomics Inc. (NEO) Buy with a $28 price target, as of its latest action on Oct 6, 2026. It has published 4 rating actions on NEO since May 2023, including 2 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- $28
- Median target, all firms
- Too few
- Actions on NEO
- 4
BTIG price target on NEO
Every BTIG rating on NEO
- Oct 6, 2026
- Jul 30, 2025DowngradeBTIG downgrades to Neutral from Buy
- Dec 29, 2023
- May 9, 2023
How other firms rate NEO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BTIG | Buy | $28 | Oct 6, 2026 |
| Leerink Partners | Outperform | $25 | Apr 29, 2026 |
Questions about BTIG and NEO
- What is BTIG's price target for NEO?
- BTIG's latest stated price target for NeoGenomics Inc. (NEO) is $28, from its action on Oct 6, 2026.
- What is BTIG's rating on NEO?
- BTIG rates NEO Buy, a bullish rating, as of Oct 6, 2026.
- When did BTIG last change its view on NEO?
- On Oct 6, 2026, BTIG upgrades to Buy from Neutral, price target $28.
More NEO rating histories
All BTIG ratingsNEO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.